Valuation (97%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.52 | 12.02 |
| PEG Ratio (TTM) | 1.49 | 3.36 |
| P/S Ratio (TTM) | 0.68 | 2.41 |
| P/B Ratio (TTM) | 0.69 | 1.33 |
| P/FCF Ratio (TTM) | 13.72 | -0.90 |
| Price to 5YR AVG Earnings Ratio | 14.41 | 21.02 |
| Price to 5YR AVG FCF Ratio | 2.07 | 15.40 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.67% | 0.96% |
| ROE (TTM) | 12.51% | 11.52% |
| Net Profit Margin (TTM) | 12.23% | 21.32% |
| ROIC 5YR AVG | 12.28% | 16.87% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.64% | -19.29% | -2.96% |
| Revenue | 35.12% | -0.63% | 4.01% |
| Net Income | 4.86% | -9.83% | 0.81% |
| Cash Flow | -25.29% | 612.30% | 395.31% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.30 | 1.69 |
| Quick Ratio (TTM) | 1.24 | 1.58 |
| D/E Ratio (TTM) | 4.55 | 2.38 |
| Interest Coverage (TTM) | 0.72 | 0.56 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.33 | 0.42 |
| LTL to 5YR AVG FCF | 8.77 | 13.77 |
| Shares Outstanding Growth 5YR AVG | 0.08% | -0.98% |